The FDA has approved berotralstat oral pellets for prophylactic use in patients aged 2 to than 12 years with hereditary ...
The judge determined the formula caused the roughly one-pound premature baby to develop necrotizing enterocolitis (NEC), a ...
BioCryst secures FDA approval for Orladeyo oral pellets, expanding preventive HAE therapy to children ages 2 to under 12.
The tragic newborn — known only as “John Doe” Santiago-Sanchez — died of exposure to the potent drug and his placement in the ...
We tested adult diapers in our labs and got feedback from regular users to find the very best adult diapers and incontinence underwear.
The FDA approval of berotralstat oral pellets offers a new prophylaxis option for children aged 2 years and older with hereditary angioedema.
In the past month alone, unusual births have made headlines across the country: a baby girl nicknamed “Little Buc-ee” arrived ...